<!DOCTYPE html>
<html style="font-size: 16px;" lang="en"><head>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <meta name="keywords" content="​What is Verteporfin?, Join the Community">
    <meta name="description" content="">
    <title>Home</title>
    <link rel="stylesheet" href="nicepage.css" media="screen">
<link rel="stylesheet" href="Home.css" media="screen">
    <script class="u-script" type="text/javascript" src="jquery.js" defer=""></script>
    <script class="u-script" type="text/javascript" src="nicepage.js" defer=""></script>
    <meta name="generator" content="Nicepage 6.7.6, nicepage.com">
    <link id="u-theme-google-font" rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i|Open+Sans:300,300i,400,400i,500,500i,600,600i,700,700i,800,800i">
    <link id="u-page-google-font" rel="stylesheet" href="https://fonts.googleapis.com/css?family=Titillium+Web:200,200i,300,300i,400,400i,600,600i,700,700i,900">
    
    
    
    
    
    <script type="application/ld+json">{
		"@context": "http://schema.org",
		"@type": "Organization",
		"name": ""
}</script>
    <meta name="theme-color" content="#478ac9">
    <meta property="og:title" content="Home">
    <meta property="og:type" content="website">
  <meta data-intl-tel-input-cdn-path="intlTelInput/"></head>
  <body data-path-to-root="./" data-include-products="false" class="u-body u-xl-mode" data-lang="en"><header class="u-clearfix u-header u-palette-2-base u-sticky u-sticky-99bf u-header" id="sec-1dd3"><div class="u-clearfix u-sheet u-sheet-1">
        <h3 class="u-custom-font u-font-titillium-web u-headline u-text u-text-default u-text-1">
          <a class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-body-alt-color u-btn-1" data-href="http://verteporfin.us.to">Verteporfin<br>
          </a>
        </h3>
      </div></header>
    <section class="u-align-center u-clearfix u-section-1" id="carousel_53e1">
      <div class="u-clearfix u-sheet u-sheet-1">
        <h2 class="u-custom-font u-font-titillium-web u-text u-text-default u-text-palette-2-base u-text-1"> What is Verteporfin?<br>
        </h2>
        <div class="u-border-8 u-border-palette-2-base u-line u-line-horizontal u-line-1"></div>
        <p class="u-text u-text-grey-60 u-text-2"> Verteporfin is a medication primarily used in photodynamic therapy to treat certain eye conditions, such as macular degeneration. Research suggests that verteporfin may have potential applications in scar healing by modulating cell signaling pathways involved in tissue repair and regeneration.</p>
        <img src="images/Verteporfin.svg" alt="" class="u-expanded-width u-image u-image-contain u-image-default u-image-1" data-image-width="2010" data-image-height="2330">
      </div>
    </section>
    <section class="u-align-center u-clearfix u-image u-shading u-section-2" id="sec-084a">
      <div class="u-clearfix u-sheet u-sheet-1">
        <h1 class="u-align-center u-text u-text-default u-title u-text-1">Join the Community</h1>
        <p class="u-align-center u-large-text u-text u-text-default u-text-variant u-text-2">To learn more, join our Telegram community of more than 500 members!</p>
        <a href="https://t.me/+2nasLt-OCA04NGQx" class="u-align-center u-btn u-button-style u-palette-2-base u-btn-1" target="_blank">Join Now!<br>
        </a>
      </div>
    </section>
    <section class="u-align-left u-clearfix u-section-3" id="sec-4ed4">
      <div class="u-clearfix u-sheet u-sheet-1">
        <h2 class="u-align-center u-custom-font u-font-titillium-web u-text u-text-default u-text-1" data-animation-name="customAnimationIn" data-animation-duration="1500" data-animation-delay="0">Trials &amp; Case Studies<br>
        </h2>
        <p class="u-align-center u-text u-text-2" data-animation-name="customAnimationIn" data-animation-duration="1500" data-animation-delay="250">Collection of research chronologically sorted.<br>
        </p>
        <div class="u-expanded-width u-tab-links-align-justify u-tabs u-tabs-1">
          <ul class="u-spacing-10 u-tab-list u-unstyled" role="tablist"><li class="u-tab-item" role="presentation"><a class="active u-active-palette-2-base u-button-style u-tab-link u-tab-link-1" id="link-tab-081f" href="#tab-081f" role="tab" aria-controls="tab-081f" aria-selected="true"> April 23, 2021 - Dr. Michael Longaker publishes revolutionary paper</a>
</li><li class="u-tab-item" role="presentation"><a class="u-active-palette-2-base u-button-style u-tab-link u-tab-link-2" id="link-tab-1fad" href="#tab-1fad" role="tab" aria-controls="tab-1fad" aria-selected="false">May 9, 2022 - @KK on Telegram starts his VP journey</a>
</li><li class="u-tab-item" role="presentation"><a class="u-active-palette-2-base u-button-style u-tab-link u-tab-link-3" id="link-tab-f8fb" href="#tab-f8fb" role="tab" aria-controls="tab-f8fb" aria-selected="false">July 22, 2022 - Dr. Taleb Bargouthi starts testing VP on FUE hairtransplant</a>
</li><li class="u-tab-item" role="presentation"><a class="u-active-palette-2-base u-button-style u-tab-link u-tab-link-4" id="link-tab-7fca" href="#tab-7fca" role="tab" aria-controls="tab-7fca" aria-selected="false">June 7, 2023 - ​@sc0t on Telegram starts his VP journey</a>
</li><li class="u-tab-item" role="presentation"><a class="u-active-palette-2-base u-button-style u-tab-link u-tab-link-5" id="link-tab-b284" href="#tab-b284" role="tab" aria-controls="tab-b284" aria-selected="false">July 11, 2023 - Dr. Blake Bloxham starts testing VP on FUT hairtransplant<br>
</a>
</li></ul>
          <div class="u-tab-content">
            <div class="u-container-style u-shape-rectangle u-tab-active u-tab-pane u-tab-pane-1" id="tab-081f" role="tabpanel" aria-labelledby="link-tab-081f">
              <div class="u-container-layout u-valign-bottom-lg u-valign-bottom-md u-valign-bottom-sm u-container-layout-1">
                <h4 class="u-text u-text-default-xl u-text-3">Description</h4>
                <div class="u-align-left u-border-3 u-border-grey-dark-1 u-line u-line-horizontal u-line-1"></div>
                <p class="u-text u-text-default u-text-4"> On April 23rd, 2021, Dr. Michael Longaker, Stanford’s vice chair of surgery, and Geoffrey Gurtner, Stanford’s vice president of surgery for innovation, published a paper in Science titled “<a href="https://www.science.org/doi/full/10.1126/science.aba2374" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-1-base u-btn-1" target="_blank">Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring.</a>” This revolutionary research made it to the NYTimes. In mice they made 6 mm in diameter circular full thickness excisions, these wounds were then injected with Verteporfin and they healed to the point that verteporfin-healed skin was nearly indistinguishable from normal skin, with recovery of skin appendages, ultrastructure, and mechanical strength. This was confirmed via histological analysis and machine learning algorithms.
                </p>
                <div class="u-container-align-center-lg u-container-align-center-md u-container-align-center-sm u-container-align-center-xs u-container-style u-expanded-width u-group u-group-1">
                  <div class="u-container-layout">
                    <img class="u-align-center-lg u-align-center-md u-align-center-sm u-align-center-xs u-image u-image-contain u-image-default u-image-1" src="images/image14.png" alt="" data-image-width="1230" data-image-height="408">
                    <img class="u-align-center-lg u-align-center-md u-align-center-sm u-align-center-xs u-image u-image-contain u-image-default u-image-2" src="images/image121.png" alt="" data-image-width="1636" data-image-height="590">
                  </div>
                </div>
              </div>
            </div>
            <div class="u-container-style u-shape-rectangle u-tab-pane u-tab-pane-2" id="tab-1fad" role="tabpanel" aria-labelledby="link-tab-1fad">
              <div class="u-container-layout u-container-layout-3">
                <h4 class="u-text u-text-default u-text-5">Description</h4>
                <div class="u-align-left u-border-3 u-border-grey-dark-1 u-line u-line-horizontal u-line-2"></div>
                <p class="u-text u-text-6">On May 9th, 2022, our very own @KK from <a href="https://t.me/+2nasLt-OCA04NGQx" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-1-base u-btn-2" target="_blank">the Verteporfin Research Telegram community</a>&nbsp;was the first to start using verteporfin himself. He has since undergone many excisions of his many scars using verteporfin with some of the results, especially the facial excisions, appearing extremely impressive, causing a huge influx of members into the community. As always, this is an unscientific case study so take the results with a grain of salt. For more information and questions on this specific case, you can also join his <a href="https://t.me/+XvBW4pSKSpAyYWE0" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-1-base u-btn-3" target="_blank">own Telegram community</a>.<br>
                </p>
                <div class="u-container-style u-expanded-width u-group u-group-2">
                  <div class="u-container-layout u-valign-bottom-xl u-container-layout-4">
                    <img class="u-image u-image-default u-image-3" src="images/photo_2022-09-30_20-31-23.jpg" alt="" data-image-width="1279" data-image-height="464">
                    <img class="u-image u-image-default u-image-4" src="images/photo_2022-10-04_15-52-59.jpg" alt="" data-image-width="1280" data-image-height="1274">
                    <img class="u-image u-image-default u-image-5" src="images/photo_2023-01-30_04-56-03.png" alt="" data-image-width="561" data-image-height="757">
                  </div>
                </div>
              </div>
            </div>
            <div class="u-container-style u-shape-rectangle u-tab-pane u-tab-pane-3" id="tab-f8fb" role="tabpanel" aria-labelledby="link-tab-f8fb">
              <div class="u-container-layout u-valign-top u-container-layout-5">
                <h4 class="u-text u-text-7">Description</h4>
                <div class="u-align-left u-border-3 u-border-grey-dark-1 u-line u-line-horizontal u-line-3"></div>
                <p class="u-text u-text-default u-text-8"> On July 22nd, 2022, Dr. Barghouthi tried using verteporfin on a “test” FUE on <a href="https://verteporfin.org/latest-update/" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-1-base u-btn-4" target="_blank">his website</a>. He set up 3 control and 3 test locations across the donor region, where the control was injected with PBS and the test locations were injected with verteporfin with a concentration of 2 mg/mL, which was the concentration used in pigs, with dosages of 0.24 mg/cm^2, 0.32 mg/cm2, and 0.4 mg/cm2. These dosages were extrapolated from the mice study, as the dosages for the pig study haven’t been released.
                </p>
                <div class="u-container-align-center-md u-container-align-center-sm u-container-align-center-xs u-container-style u-expanded-width u-group u-group-3">
                  <div class="u-container-layout">
                    <img class="u-expanded-width-xs u-image u-image-default u-image-6" src="images/hair.png" alt="" data-image-width="768" data-image-height="1024">
                    <img class="u-image u-image-default u-image-7" src="images/test.png" alt="" data-image-width="1357" data-image-height="550">
                  </div>
                </div>
              </div>
            </div>
            <div class="u-container-style u-shape-rectangle u-tab-pane u-tab-pane-4" id="tab-7fca" role="tabpanel" aria-labelledby="link-tab-7fca">
              <div class="u-container-layout u-container-layout-7">
                <h4 class="u-text u-text-default u-text-9">Description</h4>
                <div class="u-align-left u-border-3 u-border-grey-dark-1 u-line u-line-horizontal u-line-4"></div>
                <p class="u-text u-text-default u-text-10"> On June 7th, 2023, our very own @sc0t from <a href="https://t.me/+2nasLt-OCA04NGQx" target="_blank" class="u-active-none u-border-none u-btn u-button-style u-hover-none u-none u-text-palette-1-base u-btn-5">the Verteporfin Research Telegram community</a>&nbsp;started using verteporfin himself. He had an indented scar on his lip and went to one of the best plastic surgeons regarding miniscule scar revisions, Dr. Yang Liu. His scar was excised and treated with verteporfin, and the result is fantastic. Because of the doctor's exceptional skill, many wonder whether the great result of this excision was due to verteporfin or the doctor, or a combination of both.&nbsp;As always, this is an unscientific case study so take the results with a grain of salt.
                </p>
                <img class="u-image u-image-default u-image-8" src="images/photo_2023-06-06_11-22-15.jpg" alt="" data-image-width="408" data-image-height="332">
                <img class="u-image u-image-default u-image-9" src="images/photo_2023-11-03_22-29-20.jpg" alt="" data-image-width="591" data-image-height="621">
              </div>
            </div>
            <div class="u-container-style u-shape-rectangle u-tab-pane u-tab-pane-5" id="tab-b284" role="tabpanel" aria-labelledby="link-tab-b284">
              <div class="u-container-layout u-valign-bottom-xl u-container-layout-8">
                <h4 class="u-text u-text-default u-text-11">Description</h4>
                <div class="u-align-left u-border-3 u-border-grey-dark-1 u-line u-line-horizontal u-line-5"></div>
                <p class="u-text u-text-default u-text-12"> On July 11th, 2023, Dr. Bloxham trialed verteporfin on 3 FUT patients on <a href="https://www.youtube.com/watch?v=_G8Fw_dBPkg" class="u-active-none u-border-none u-btn u-button-link u-button-style u-hover-none u-none u-text-palette-1-base u-btn-6" target="_blank">his YouTube channel</a>. These patients were unique; different skin-types, different histories (some had prior surgery, some did not), and different amounts of tissue were taken and tested. Some had sections of scar removed, treated with verteporfin and closed again; others had virgin tissue removed, treated with verteporfin, and closed. Differing concentrations (based upon past studies) of the medication were used as well. The study is still ongoing but results already appear promising, with more neogenesis of hair follicles being present in the treated regions, as well as healthier looking skin.
                </p>
                <div class="u-container-style u-expanded-width u-group u-group-4">
                  <div class="u-container-layout">
                    <img class="u-image u-image-default u-image-10" src="images/Screenshot2024-04-10234513.png" alt="" data-image-width="1111" data-image-height="541">
                    <img class="u-image u-image-default u-image-11" src="images/Screenshot2024-04-10234457.png" alt="" data-image-width="1435" data-image-height="542">
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>
    
    
    
    <footer class="u-align-center u-clearfix u-footer u-grey-80 u-footer" id="sec-4719"><div class="u-clearfix u-sheet u-valign-middle u-sheet-1">
        <p class="u-small-text u-text u-text-variant u-text-1"> http://verteporfin.us.to/<br>verteporfin@mail.com<br>
        </p>
      </div></footer>
  
</body></html>